Market Tracker

09/22 2:16pm ET
73.74
Real-Time Quote
 -0.11 / -0.15%
Today’s Change
10.95
Today|||52-Week Range
74.24
+400.61%
Year-to-Date

Today’s Trading

Previous close73.85
Today’s open73.72
Day’s range73.66 - 73.80
Volume1,711,214
Average volume (3 months)3,673,850
Market cap$8.0B
Dividend yield--
Data as of 2:01pm ET, 09/22/2014

Growth & Valuation

Earnings growth (last year)-17.39%
Earnings growth (this year)-1.59%
Earnings growth (next 5 years)+60.00%
Revenue growth (last year)+168.74%
P/E ratioNM
Price/Sales17.04
Price/Book49.28

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA-0.80-2.14%
GEVASynageva BioPharma C...-3.99-6.16%
XONIntrexon Corp-1.59-7.88%
OPHTOphthotech Corp-1.10-2.82%
Data as of 2:15pm ET, 09/22/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$70.3M
Annual profit (last year)-$219.6M
Net profit margin-313.88%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Daniel G. Welch
Executive VP, Chief Financial &
Accounting Officer
John C. Hodgman
Corporate headquarters
Brisbane, California

Forecasts